RHOEN-KLINIKUM AG ORD NPVRHOEN-KLINIKUM AG ORD NPVRHOEN-KLINIKUM AG ORD NPV

RHOEN-KLINIKUM AG ORD NPV

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪863.51 M‬EUR
‪38.71 M‬EUR
‪1.67 B‬EUR
‪4.41 M‬
Beta (1Y)
0.69

About RHOEN-KLINIKUM AG

CEO
Tobias Kaltenbach
Headquarters
Bad Neustadt an der Saale
Employees (FY)
‪18.25 K‬
Founded
1973
ISIN
DE0007042301
FIGI
BBG000KNW108
Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0NQH is 13.0 EUR — it has increased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange RHOEN-KLINIKUM AG ORD NPV stocks are traded under the ticker 0NQH.
RHOEN-KLINIKUM AG ORD NPV is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0NQH stock is 0.77% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is RHOEN-KLINIKUM AG ORD NPV there?
RHOEN-KLINIKUM AG ORD NPV revenue for the last quarter amounts to ‪320.00 M‬ EUR despite the estimated figure of ‪318.40 M‬ EUR. In the next quarter revenue is expected to reach ‪319.25 M‬ EUR.
Yes, you can track RHOEN-KLINIKUM AG ORD NPV financials in yearly and quarterly reports right on TradingView.
0NQH stock has risen by 17.73% compared to the previous week, the month change is a 17.73% rise, over the last year RHOEN-KLINIKUM AG ORD NPV has showed a 1.52% decrease.
0NQH net income for the last quarter is ‪15.55 M‬ EUR, while the quarter before that showed ‪11.17 M‬ EUR of net income which accounts for 39.21% change. Track more RHOEN-KLINIKUM AG ORD NPV financial stats to get the full picture.
Today RHOEN-KLINIKUM AG ORD NPV has the market capitalization of ‪863.51 M‬, it has increased by 6.31% over the last week.
Yes, 0NQH dividends are paid annually. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 1.16%. Tracking RHOEN-KLINIKUM AG ORD NPV dividends might help you take more informed decisions.
Like other stocks, 0NQH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RHOEN-KLINIKUM AG ORD NPV stock right from TradingView charts — choose your broker and connect to your account.
0NQH reached its all-time high on Mar 2, 2017 with the price of 33.8 EUR, and its all-time low was 9.6 EUR and was reached on Feb 13, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪18.25 K‬ employees. See our rating of the largest employees — is RHOEN-KLINIKUM AG ORD NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RHOEN-KLINIKUM AG ORD NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RHOEN-KLINIKUM AG ORD NPV stock shows the neutral signal. See more of RHOEN-KLINIKUM AG ORD NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RHOEN-KLINIKUM AG ORD NPV EBITDA is ‪50.05 M‬ EUR, and current EBITDA margin is 2.73%. See more stats in RHOEN-KLINIKUM AG ORD NPV financial statements.